MRI fusion prostate biopsy combines MRI and ultrasound images, allowing for more precise and targeted sampling. This enables biopsy samples to be taken from suspicious areas rather than randomly, as in conventional biopsy.
MR fusion prostate biopsy is a procedure that uses magnetic resonance imaging (MRI) and ultrasound techniques combined with computer software to obtain a highly sensitive tissue sample from the prostate.
In MR fusion prostate biopsy, the MRI image of the patient's prostate is converted into a 3D image using the same device and combined with ultrasound (Transrectal Ultrasonography-TRUS) images. This creates a detailed, 3D image of the prostate, and tissue sampling is performed using a needle within the same device. Using data from two imaging methods in a fusion (overlapping) manner allows for more detailed visualization of areas in the prostate and increases the success rate of the biopsy procedure. The biopsy sample is taken by guiding a needle at the end of a mechanical arm directly to the suspicious area in the image.
MR fusion technology makes it easier to differentiate between cancer and low-risk diseases because it more accurately shows the anatomy of the prostate and the location of lesions.
Transrectal MR fusion biopsy involves taking a sample of prostate tissue by passing a biopsy needle through the rectum (the final part of the large intestine). An ultrasound probe is advanced through the rectum, and the biopsy needle is guided to the area visualized by MR fusion. Since transrectal MR fusion biopsy is performed rectally, the risk of infection is relatively high; therefore, antibiotic treatment may be initiated before or after the procedure.
Transperineal MR fusion biopsy involves obtaining a sample of prostate tissue by advancing a biopsy needle through the perineum (the area of skin between the scrotum and the anus). Because the procedure is performed directly through the skin without puncturing the rectal mucosa, the risk of infection and sepsis is relatively lower compared to transrectal MR fusion biopsy.
For MR Fusion Prostate Biopsy, an MRI of the patient's prostate is performed first, and suspicious areas are marked. These MRI images are combined with live transrectal or transperineal ultrasound images. Thanks to the combined imaging (fusion), the biopsy needle is precisely guided to the targeted area, and tissue samples are taken from the region to be examined. During the procedure, the ultrasound probe and biopsy needle are visualized simultaneously. Multiple samples are taken from each lesion, therefore the number of needles may vary. MR Fusion Prostate Biopsy takes between 30 and 60 minutes, and local anesthesia is usually preferred.
Before an MR fusion prostate biopsy, the patient should be informed about the procedure, necessary tests should be completed, and their regularly used medications should be adjusted if necessary. The following points should be considered before an MR fusion prostate biopsy:
After an MR fusion prostate biopsy, the patient can go home the same day, but depending on other health problems and complications that occurred during the procedure, it may be necessary to stay under observation for 1-2 hours afterwards. Things to keep in mind after an MR fusion prostate biopsy are as follows:
MR fusion prostate biopsy combines two different imaging methods, allowing for accurate visualization and targeting of all tissues in the prostate, revealing hidden areas. Thanks to MR fusion prostate biopsy, sufficient samples are taken from problematic areas instead of unnecessarily removing a large amount of tissue.
Like any invasive procedure, MR fusion prostate biopsy carries some risks. Mild blood in the urine, blood in the semen, and rectal bleeding are normal after the procedure. These complications usually resolve spontaneously within 1 to 7 days. Because transrectal MR fusion biopsy carries a risk of infection and sepsis, a specialist may prescribe antibiotics before the procedure. Sometimes, urinary incontinence may occur, requiring temporary catheterization. Increased pelvic pain, bleeding, and high fever strongly advise seeking medical attention.
MR fusion prostate biopsy is often preferred for diagnosing prostate cancer. MR fusion prostate biopsy can be performed to diagnose the following conditions:
In a classic prostate biopsy, tissue samples are taken randomly from different areas of the prostate using ultrasound, and this method can miss cancer. MR fusion prostate biopsy matches (fusions) previously taken multiparametric MRI images with ultrasound, allowing suspicious lesions to be directly targeted and the biopsy sample to be collected in a more focused manner.
MR fusion prostate biopsy is usually performed under local anesthesia, but the final decision regarding anesthesia should be made by a specialist physician.
The pathology results for MR fusion prostate biopsy vary depending on where the procedure is performed, but the pathology report is typically ready within 7 to 14 days.
The price of an MR fusion prostate biopsy varies depending on the healthcare center and insurance coverage. For exact pricing information, please contact the hospital or clinic where the procedure will be performed.
MR fusion prostate biopsy is safe when performed by an experienced team, but like any invasive procedure, it carries some risks. The level of difficulty varies depending on the biopsy method (transrectal vs. transperineal) and the patient's overall health.
Other Featured Technologies
Creation Date:31.03.2026
Update Date:31.03.2026
Created by:Medipol Health Group Web Editorial Board